Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

311 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
Larsson T, Nisbeth U, Ljunggren O, Jüppner H, Jonsson KB. Larsson T, et al. Among authors: juppner h. Kidney Int. 2003 Dec;64(6):2272-9. doi: 10.1046/j.1523-1755.2003.00328.x. Kidney Int. 2003. PMID: 14633152
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl.
Martin KJ, Jüppner H, Sherrard DJ, Goodman WG, Kaplan MR, Nassar G, Campbell P, Curzi M, Charytan C, McCary LC, Guo MD, Turner SA, Bushinsky DA. Martin KJ, et al. Among authors: juppner h. Kidney Int. 2005 Sep;68(3):1236-43. doi: 10.1111/j.1523-1755.2005.00517.x. Kidney Int. 2005. PMID: 16105056 Clinical Trial.
Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Jüppner H. Salusky IB, et al. Among authors: juppner h. Kidney Int. 2003 May;63(5):1801-8. doi: 10.1046/j.1523-1755.2003.00915.x. Kidney Int. 2003. PMID: 12675856
Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy.
Goodman WG, Jüppner H, Salusky IB, Sherrard DJ. Goodman WG, et al. Among authors: juppner h. Kidney Int. 2003 Jan;63(1):1-11. doi: 10.1046/j.1523-1755.2003.00700.x. Kidney Int. 2003. PMID: 12472763 Review.
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.
Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K. Pereira RC, et al. Among authors: juppner h. Bone. 2009 Dec;45(6):1161-8. doi: 10.1016/j.bone.2009.08.008. Epub 2009 Aug 11. Bone. 2009. PMID: 19679205 Free PMC article.
Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
Wesseling-Perry K, Tsai EW, Ettenger RB, Jüppner H, Salusky IB. Wesseling-Perry K, et al. Among authors: juppner h. Nephrol Dial Transplant. 2011 Nov;26(11):3779-84. doi: 10.1093/ndt/gfr126. Epub 2011 Mar 25. Nephrol Dial Transplant. 2011. PMID: 21441401 Free PMC article.
Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis.
Dasgupta D, Wee MJ, Reyes M, Li Y, Simm PJ, Sharma A, Schlingmann KP, Janner M, Biggin A, Lazier J, Gessner M, Chrysis D, Tuchman S, Baluarte HJ, Levine MA, Tiosano D, Insogna K, Hanley DA, Carpenter TO, Ichikawa S, Hoppe B, Konrad M, Sävendahl L, Munns CF, Lee H, Jüppner H, Bergwitz C. Dasgupta D, et al. Among authors: juppner h. J Am Soc Nephrol. 2014 Oct;25(10):2366-75. doi: 10.1681/ASN.2013101085. Epub 2014 Apr 3. J Am Soc Nephrol. 2014. PMID: 24700880 Free PMC article.
Fibroblast growth factor 23: fueling the fire.
Hanudel M, Jüppner H, Salusky IB. Hanudel M, et al. Among authors: juppner h. Kidney Int. 2016 Nov;90(5):928-930. doi: 10.1016/j.kint.2016.08.013. Kidney Int. 2016. PMID: 27742194 Free PMC article.
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.
Isakova T, Gutiérrez OM, Smith K, Epstein M, Keating LK, Jüppner H, Wolf M. Isakova T, et al. Among authors: juppner h. Nephrol Dial Transplant. 2011 Feb;26(2):584-91. doi: 10.1093/ndt/gfq419. Epub 2010 Jul 14. Nephrol Dial Transplant. 2011. PMID: 20631407 Free PMC article. Clinical Trial.
We analysed serial measurements of FGF23, parathyroid hormone, serum phosphate and calcium, and 24-h urinary phosphate and calcium excretion using repeated-measures analyses. RESULTS: Compared with the 1500-mg phosphorus diet, patients assigned to the 750-mg diet had great …
We analysed serial measurements of FGF23, parathyroid hormone, serum phosphate and calcium, and 24-h urinary phosphate and calcium ex …
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.
Wesseling-Perry K, Pereira RC, Sahney S, Gales B, Wang HJ, Elashoff R, Jüppner H, Salusky IB. Wesseling-Perry K, et al. Among authors: juppner h. Kidney Int. 2011 Jan;79(1):112-9. doi: 10.1038/ki.2010.352. Epub 2010 Sep 22. Kidney Int. 2011. PMID: 20861820 Clinical Trial.
311 results
Jump to page
Feedback